NCT00101712
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Investigative Site, Germany
- Novartis Investigative Site Basel, Switzerland
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
2,679 public trials
157 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT00351585
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified
Completed
Efficacy and Safety of Vildagliptin Compared to Acarbose in Drug Naive Patients With Type 2 Diabetes
NCT00110240
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland
Completed
Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes
NCT00099944
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
NCT00101673
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland
NCT00138619
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States
- Investigative Centers, Germany
Completed
Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes
NCT00099931
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Investigative Site Investigative Sites, Germany
Completed
A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes
NCT00351546
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
Not specified
NCT00099957
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals Basel, Switzerland
NCT00099905
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States